Introduction of Continuous Glucose Monitoring Technology

  • J. Y. Lu
  • Y. BaoEmail author


Continuous glucose monitoring (CGM) technology can continuously monitor the glucose concentration in subcutaneous interstitial fluid through a glucose sensor, providing a glycemic profile throughout the day. CGM is able to detect occult hyperglycemia and hypoglycemia that cannot easily be detected by traditional glucose monitoring methods. In addition, CGM facilitates the understanding of the influence of diet, exercise, drugs, and other factors on blood glucose, prompting patients to establish a healthy lifestyle and improve patients’ adherence. Therefore, it plays an irreplaceable role in glucose monitoring for diabetes patients. Since CGM system detects glucose concentration through glucose sensors, the development of CGM is largely dependent on the evolution of glucose sensors. In 1999, MiniMed Inc. introduced the world’s first subcutaneously implanted glucose sensor and since then has initiated the clinical application of CGM. This chapter will discuss the development of CGM and the technical characteristics of common CGM equipment on the market.


Subcutaneous Interstitial fluid Glucose sensor Continuous glucose monitoring 


  1. 1.
    Chinese Diabetes Society. Chinese clinical guideline for continuous glucose monitoring (2012). Chin J Diabetes Mellitus. 2012;4:582–90. Scholar
  2. 2.
    Clark LC Jr, Lyons C. Electrode systems for continuous monitoring in cardiovascular surgery. Ann N Y Acad Sci. 1962;102:29–45.CrossRefGoogle Scholar
  3. 3.
    Bankar SB, Bule MV, Singhal RS, Ananthanarayan L. Glucose oxidase–an overview. Biotechnol Adv. 2009;27:489–501. Scholar
  4. 4.
    Heller A, Feldman B. Electrochemical glucose sensors and their applications in diabetes management. Chem Rev. 2008;108:2482–505. Scholar
  5. 5.
    Updike SJ, Hicks GP. The enzyme electrode. Nature. 1967;214:986–8.CrossRefGoogle Scholar
  6. 6.
    Cass AE, Davis G, Francis GD, Hill HA, Aston WJ, Higgins IJ, Plotkin EV, Scott LD, Turner AP. Ferrocene-mediated enzyme electrode for amperometric determination of glucose. Anal Chem. 1984;56:667–71.CrossRefPubMedGoogle Scholar
  7. 7.
    Matthews DR, Holman RR, Bown E, Steemson J, Watson A, Hughes S, Scott D. Pen-sized digital 30-second blood glucose meter. Lancet. 1987;1:778–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Palmisano F, Zambonin PG, Centonze D, Quinto M. A disposable, reagentless, third-generation glucose biosensor based on overoxidized poly (pyrrole) /tetrathiafulvalene–tetracyanoquinodimethane composite. Anal Chem. 2002;74:5913–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W, Schipper H, Gander R. Clinical control of diabetes by the artificial pancreas. Diabetes. 1974;23:397–404.CrossRefPubMedGoogle Scholar
  10. 10.
    Shichiri M, Kawamori R, Yamasaki Y, Hakui N, Abe H. Wearable artificial endocrine pancreas with needle-type glucose sensor. Lancet. 1982;2:1129–31.CrossRefPubMedGoogle Scholar
  11. 11.
    Liu XF, Liu C. Comparison of several common continuous glucose monitoring systems. Int J Endocrinol Metab. 2009;29:197–200. Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. and Shanghai Scientific and Technical Publishers 2018

Authors and Affiliations

  1. 1.Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes InstituteShanghai Jiao Tong University, Affiliated Sixth People’s HospitalShanghaiChina

Personalised recommendations